Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - pramipexole dihydrochloride monohydrate, quantity: 1.5 mg - tablet - excipient ingredients: pregelatinised maize starch; mannitol; microcrystalline cellulose; povidone; purified talc; magnesium stearate - the treatment of signs and symptoms of idiopathic parkinson's disease. it may be used as monotherapy or in combination with levodopa.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - pramipexole dihydrochloride monohydrate, quantity: 0.5 mg - tablet - excipient ingredients: pregelatinised maize starch; mannitol; microcrystalline cellulose; povidone; purified talc; magnesium stearate - the treatment of signs and symptoms of idiopathic parkinson's disease. it may be used as monotherapy or in combination with levodopa.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - pramipexole dihydrochloride monohydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - pramipexole dihydrochloride monohydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - pramipexole dihydrochloride monohydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - pramipexole dihydrochloride monohydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - pramipexole dihydrochloride monohydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - carbidopa monohydrate, quantity: 5 mg/ml; levodopa, quantity: 20 mg/ml - gel - excipient ingredients: purified water; carmellose sodium - for the treatment of advanced idiopathic parkinson?s disease with severe motor fluctuations despite optimised alternative pharmacological treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

mannatech australia pty ltd - aloe vera,calcium citrate tetrahydrate,creatine monohydrate,choline bitartrate,fructose,ghatti gum,lecithin,magnesium aspartate dihydrate,magnesium gluconate,potassium aspartate,potassium gluconate,tragacanth -

Australia - English - Department of Health (Therapeutic Goods Administration)

lundbeck australia pty ltd - aripiprazole, quantity: 400 mg (equivalent: aripiprazole monohydrate, qty 416.07 mg) - injection, powder for - excipient ingredients: carmellose sodium; mannitol; monobasic sodium phosphate monohydrate; sodium hydroxide; water for injections - for the acute and maintenance treatment of schizophrenia in adults. for maintenance treatment to prevent the recurrence of manic or mixed episodes of bipolar i disorder in adult patients as monotherapy.